Akari Therapeutics Announces FDA Fast Track Designation For Coversin

Mar 30, 2017 20:02 pm UTC| Business

NEW YORK and LONDON, March 30, 2017 -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has granted Fast...

Molecular Templates Announces Presentations Featuring Engineered Toxin Bodies at the 2017 American Association for Cancer Research (AACR) Annual Meeting

Mar 30, 2017 20:01 pm UTC| Business

AUSTIN, Texas, March 30, 2017 -- Molecular Templates, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapies that possess unique...

Aehr Test Systems Reports Third Quarter Fiscal 2017 Financial Results

Mar 30, 2017 20:01 pm UTC| Business

FREMONT, Calif., March 30, 2017 -- Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced financial results for its third quarter of fiscal 2017 ended February...

Sevcon to Present at The MicroCap Conference

Mar 30, 2017 20:01 pm UTC| Business

SOUTHBOROUGH, Mass., March 30, 2017 -- Sevcon, Inc. (Nasdaq:SEV) today announced that Matt Boyle, Chief Executive Officer, will present at The MicroCap Conference to be held at the Essex House in New York, NY, on...

Neovacs Provides Corporate Update and Reports Full Year 2016 Financial Results

Mar 30, 2017 20:01 pm UTC| Business

IFNα Kinoid to treat Lupus received “Fast Track” designation from FDA; Phase IIb ongoingExtended IFNα Kinoid clinical development program to Dermatomyositis; Phase IIa ongoingExtended IFNα Kinoid preclinical development...

Tetraphase Pharmaceuticals’ TP-6076 Selected by CARB-X to Receive $4 Million in Research Funding

Mar 30, 2017 20:01 pm UTC| Business

WATERTOWN, Mass., March 30, 2017 -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections,...

Navios Maritime Midstream Partners L.P. Announces Availability of Its Form 20-F for the Year Ended December 31, 2016

Mar 30, 2017 20:01 pm UTC| Business

MONACO, March 30, 2017 -- Navios Maritime Midstream Partners L.P. ("Navios Midstream") (NYSE:NAP), announced that its Annual Report on Form 20-F for the year ended December 31, 2016 has been filed with the SEC and can...